Categories AlphaGraphs, Earnings, Technology
Earnings: Tesla (TSLA) Q2 revenue up 42%; profit beats estimates
Tesla Inc. (NASDAQ: TSLA) on Wednesday said its second-quarter earnings rose sharply and topped expectations. Driving the bottom-line growth, revenues increased by 42%.
Revenues of the Austin-based electric car maker advanced 42% year-over-year to $16.9 billion during the three-month period but fell short of estimates. The company produced a total of 258,580 vehicles and delivered 254,695 units, mainly comprising the Model-3 and Model-Y variants.
Earnings, excluding one-off items, climbed to $2.27 per share in the second quarter from $1.45 per share a year earlier. Experts were looking for slower growth. Second-quarter unadjusted net income moved up to $2.26 billion or $1.95 per share from $1.14 billion or $1.02 per share in the same period of 2021.
Check this space to read management/analysts’ comments on Tesla’s Q2 report
TSLA’s market value increased in the past twelve months. The stock closed Wednesday’s regular trading higher and gained further in the extended session soon after the announcement.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results
Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to
Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?
The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market
Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term
Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited
